The startup’s first prospect is a heart medicine that works differently than the hypertrophic cardiomyopathy drugs developed ...

Immutep's eftilagimod shows a 17.6-month survival benefit in head and neck cancer. Find out how and why IMMP is continuing to develop in the right direction.

EV-Grade Durability: Featuring advanced LiFePO4 battery tech, the Exodus 2400 retains 80% capacity after 3,500 cycles-enough ...